Assignee
SANTHERA PHARMACEUTICALS CH
CH·4 granted patents·9 pending applications·16 citations·filing 2002–2009
Top patents by PatentIndex Score
13 records- 0171US7875648B2N-(dibenz(b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiencySANTHERA PHARMACEUTICALS CH·Filed 2007·Granted Jan 25, 2011·1 cites·11 claims
- 0268US7078379B2Treatment of congenital muscular dystrophiesSANTHERA PHARMACEUTICALS CH·Filed 2002·Granted Jul 18, 2006·14 cites·8 claims
- 0362US7977388B2Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of muscular dystrophiesSANTHERA PHARMACEUTICALS CH·Filed 2006·Granted Jul 12, 2011·1 cites·19 claims
- 0450US2007259837A1Use of Non-Glucocorticoid Steroids for the Treatment of Muscular DystrophySANTHERA PHARMACEUTICALS CH·Filed 2005·Application pending·0 cites
- 0548US7999002B2Use of N-(dibenz(b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) or a pharmaceutically acceptable addition salt thereof for the prophylaxis and/or treatment of muscular dystrophySANTHERA PHARMACEUTICALS CH·Filed 2006·Granted Aug 16, 2011·0 cites·9 claims
- 0643US2010324036A1Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonistsSANTHERA PHARMACEUTICALS CH·Filed 2008·Application pending·0 cites
- 0741US2011092469A1Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophySANTHERA PHARMACEUTICALS CH·Filed 2009·Application pending·0 cites
- 0839US2011086836A1Substituted Phenylpiperidine Derivatives As Melanocortin-4 Receptor ModulatorsSANTHERA PHARMACEUTICALS CH·Filed 2007·Application pending·0 cites
- 0939US2010249093A1Substituted Heteroarylpiperidine Derivatives As Melanocortin-4 Receptor ModulatorsSANTHERA PHARMACEUTICALS CH·Filed 2008·Application pending·0 cites
- 1037US2008064728A1Heterocyclic Compounds Useful as Dpp-Iv InhibitorsSANTHERA PHARMACEUTICALS CH·Filed 2005·Application pending·0 cites
- 1133US2009208425A1Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinoneSANTHERA PHARMACEUTICALS CH·Filed 2007·Application pending·0 cites
- 1233US2007293486A1Alpha-Keto Carbonyl Calpain InhibitorsSANTHERA PHARMACEUTICALS CH·Filed 2005·Application pending·0 cites
- 1333US2008058324A1Alpha-Keto Carbonyl Calpain InhibitorsSANTHERA PHARMACEUTICALS CH·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SANTHERA PHARMACEUTICALS CH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →